About this trial
The aim of this study is to assess the benefits of using the Anchorfast device in reducing complications associated with intubation tube fixation, in terms of the rate of pressure ulcer development, the rate of intubation tube mobilization and the rate of VAP occurrence. If the hypothesis is confirmed, this project would enable the caregivers to optimize the current practice in the interests of both patients and caregivers. That's why the investigators have designed a real-life study, and will also be looking at the effect of care load on and caregiver satisfaction.
Eligibility criteria
Qualifiers
Patient over 18 years old,
Patient with orotracheal intubation,
Patient intubated no more than 24 hours previously,
Oral consent from patient, trusted support person or relative if unable to consent
Disqualifiers
Pre-existing facial, labial or auricular skin lesions,
Pre-existing mucositis,
Patients extubated for more than 24 hours whose condition requires a new intubation tube
Nasotracheal intubation,
Trial design
Treatments tested in this trial
- Corded tube care
- Tube care attached by AnchorFast
- Caregiver's evaluation on each tube fixation